-
Morning Watch List: Coherus Biosciences (NASDAQ:CHRS), Hewlett-Packard Company (NYSE:HPQ), American Midstream Partners, LP (NYSE:AMID), BlackBerry Ltd (NASDAQ:BBRY), Life Time Fitness (NYSE:LTM)
On Wednesday shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) closed at $26.53. Company’s EPS growth for next 5 years is recorded as 2.00%. Coherus BioSciences, Inc. (NASDAQ:CHRS) and Baxter International Inc. (NYSE:BAX) announced that they have amended certain financial terms of their collaboration agreement established in August 2013 regarding the development and commercialization of CHS-0214, an…
-
Momentum Stocks: OvaScience (NASDAQ:OVAS), Coherus Biosciences (NASDAQ:CHRS), Standex Int’l Corp. (NYSE:SXI), CUI Global (NASDAQ:CUI), Compugen (NASDAQ:CGEN)
On Thursday shares of OvaScience, Inc. (NASDAQ:OVAS) closed at $48.29. On March 21, it was reported that, OvaScience Inc (Nasdaq:OVAS) has elected Michelle Dipp, M.D., Ph.D., to join the World Economic Forum’s Young Global Leaders. She is being recognized for her commitment to the global community and contributions to the healthcare industry led to her…
-
Shining on Major News: Targacept (NASDAQ:TRGT), Coherus Biosciences (NASDAQ:CHRS), Community Trust Bancorp Inc. (NASDAQ:CTBI), MeadWestvaco Corporation (NYSE:MWV), Burlington Stores (NYSE:BURL)
On Tuesday shares of Targacept, Inc. (NASDAQ:TRGT) closed at $2.86. Company’s sales growth for last 5 years was -58.70%. Targacept, Inc. (NASDAQ: TRGT) terminated the employment of Steven M. Toler, PharmD., Ph.D., Vice President, Clinical Pharmaceutical Sciences of the Company, effective March 31, 2015. Coherus Biosciences, Inc. (NASDAQ:CHRS) in last trading activity advanced 6.17% to…
-
Don’t Miss: Coherus Biosciences (NASDAQ:CHRS), Apple Inc. (NASDAQ:AAPL), Facebook Inc (NASDAQ:FB), EnLink Midstream, LLC (NYSE:ENLC), Microsoft Corporation (NASDAQ:MSFT)
On Tuesday shares of Coherus Biosciences, Inc. (NASDAQ:CHRS) closed at $27.18. Company’s EPS growth for next 5 years is recorded as 2.00%. Coherus BioSciences (NASDAQ: CHRS) reported Q4 EPS of ($1.47), versus ($3.68) reported last year. Revenue for the quarter came in at $6.5 million, versus $1.2 million reported last year. Also filed to sell…
-
Active Movers: Apple Inc. (NASDAQ:AAPL), Coherus Biosciences (NASDAQ:CHRS), City National Corporation (NYSE:CYN), Sprint Corporation (NYSE:S), Discovery Communications (NASDAQ:DISCA)
Apple Inc. (NASDAQ:AAPL) plans to launch its Music Streaming service this coming June during its WorldwideDevelopers Conference (WWDC) event this year. No official date has been mentioned as of yet, but word are out that the Music Streaming service will be unveiled this June. On Friday shares of Apple Inc. (NASDAQ:AAPL) closed at $126.60. Company’s…
-
Best Stocks: Enzymotec (NASDAQ:ENZY), Coherus Biosciences (NASDAQ:CHRS), Johnson & Johnson (NYSE:JNJ), Matador Resources Company (NYSE:MTDR), Mobile Mini (NASDAQ:MINI)
On February 18, Enzymotec Ltd. (NASDAQ:ENZY) reported fourth-quarter profit of $1.1 million. For the year, the company reported profit of $7.8 million, or 34 cents per share. Revenue was reported as $47.1 million. On Wednesday shares of Enzymotec Ltd. (NASDAQ:ENZY) closed at $8.29. Company’s EPS growth for next 5 years is recorded as 1.00%. Coherus…
-
Market Wrap Up: Johnson & Johnson (NYSE:JNJ), Coherus Biosciences (NASDAQ:CHRS), Hewlett-Packard Company (NYSE:HPQ), Xencor (NASDAQ:XNCR), Denbury Resources Inc. (NYSE:DNR)
A Philadelphia jury said Tuesday that Johnson & Johnson (NYSE:JNJ) should pay $2.5 million to a 20-year-old autistic man from Alabama – who developed size 46 DD breasts as a young teenager – because the company failed to adequately warn of that potential side effect from his use of the antipsychotic drug Risperdal. On Tuesday…
-
Market Watch: Quidel Corp. (NASDAQ:QDEL), Coherus Biosciences (NASDAQ:CHRS), Nanometrics Incorporated (NASDAQ:NANO), MKS Instruments (NASDAQ:MKSI), Lithia Motors Inc. (NYSE:LAD)
Quidel Corp (NASDAQ: QDEL) reported Q4 EPS of $0.37, $0.28 better than the analyst estimate of $0.09. Revenue for the quarter came in at $63.6 million versus the consensus estimate of $61.05 million. On Thursday shares of Quidel Corp. (NASDAQ:QDEL) closed at $24.83. Company’s sales growth for last 5 years was 6.50% and EPS growth…
-
Hot Runners: Histogenics Corporation (NASDAQ:HSGX), Coherus Biosciences (NASDAQ:CHRS), Derma Sciences Inc. (NASDAQ:DSCI), VeriFone Systems (NYSE:PAY), Ameris Bancorp (NASDAQ:ABCB)
On Feb. 2, Histogenics Corporation (NASDAQ:HSGX) announced the appointment of David Gill to its board of directors and chairman of the audit committee. Mr. Gill is currently the Chief Financial Officer of EndoChoice, Inc., a medical device company which provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal (GI)…